Abstract
The basis of treatment for advanced germ cell tumors is chemotherapy and surgical resection of residual disease. Surgery has maintained its role in staging and therapeutic management. Despite these advances, much of the outcomes depend on proper patient selection. Complete removal of all post-chemotherapy residual masses remains the standard of care in the treatment of advanced nonseminomatous germ cell tumors both within and outside of the retroperitoneum.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 98-101 |
| Number of pages | 4 |
| Journal | Indian Journal of Urology |
| Volume | 26 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2010 |
| Externally published | Yes |
Keywords
- Cancer
- Testis
ASJC Scopus subject areas
- Urology
Fingerprint Dive into the research topics of 'Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis'. Together they form a unique fingerprint.
Cite this
Fitzgerald, J. P., Ercole, B., & Parekh, D. J. (2010). Management of post-chemotherapy residual mass in patients with metastatic nonseminomatous germ cell tumors of the testis. Indian Journal of Urology, 26(1), 98-101. https://doi.org/10.4103/0970-1591.60448